Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry
Vince Biemans(Radboud University Nijmegen), Fiona D M van Schaik(University Medical Center Utrecht), Jasmijn A M Sleutjes(Erasmus MC), Adriaan A. van Bodegraven(Maastricht University Medical Centre), Mark Löwenberg(Amsterdam University Medical Centers), Bas Oldenburg(University Medical Center Utrecht), Nidhi Srivastava, Marieke Pierik(Maastricht University Medical Centre), Annemarie C. de Vries(Erasmus MC), Frank Hoentjen(Radboud University Nijmegen), Alexander Bodelier(Amphia Ziekenhuis), Andrea E. van der Meulen‐de Jong(Leiden University Medical Center), Carmen S. Horjus Talabur Horje(Rijnstate Hospital), Gerard Dijkstra(University Medical Center Groningen), Rinse K. Weersma(University Medical Center Groningen), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), C. Janneke van der Woude(Radboud University Nijmegen), Rachel West(Sint Franciscus Gasthuis), Jeroen M. Jansen(OLVG), Nanne K.H. de Boer, Jildou Hoekstra(Amphia Ziekenhuis)
Cited by 87
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
|Nature Genetics|2015|2.8k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
|Circulation Research|2015|784